Novel compounds of the formula (I), in which R, R.sup.1, R.sup.2 and R.sup.3 are as defined in Patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.